Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial

Bruix, Jordi, Takayama, Tadatoshi, Mazzaferro, Vincenzo · The Lancet Oncology · 2015